Solvay SA
F:SOL

Watchlist Manager
Solvay SA Logo
Solvay SA
F:SOL
Watchlist
Price: 24.34 EUR -0.57% Market Closed
Market Cap: €2.6B

Solvay SA
Investor Relations

Solvay SA is a Belgian chemical company that sells the basic ingredients other industries use to make products. Its main output includes soda ash and sodium bicarbonate for glass, detergents, and food uses, plus chemicals such as hydrogen peroxide and silica for industrial processing, water treatment, and other manufacturing steps. Its customers are mostly other businesses, not consumers: glass makers, detergent producers, food companies, paper producers, miners, and industrial manufacturers. Solvay makes money by producing these chemicals at large scale and selling them through supply contracts and spot sales, with demand tied to factory activity and the need for steady, reliable raw materials. What makes Solvay’s role different is that it sits early in the industrial value chain. It does not sell finished consumer brands; it supplies the essential chemical inputs that many everyday products depend on, so its business is built on process know-how, manufacturing efficiency, and dependable supply rather than flashy product marketing.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Jul 29, 2026
AI Summary
Q2 2026

Q2 hit: Solvay reported underlying net sales of slightly over EUR 1 billion, down 7% year over year, and underlying EBITDA of EUR 187 million, down 20%, with the quarter hit by the Middle East conflict, weaker soda ash pricing, and one fewer one-off benefit than last year.

Guidance held: Management kept full-year 2026 guidance unchanged, still expecting EBITDA of EUR 770 million to EUR 850 million, free cash flow to Solvay shareholders above EUR 200 million, and CapEx around EUR 300 million.

Restart watch: The company said it is actively preparing to restart its peroxide plant in Saudi Arabia before the end of Q3, and management framed that restart as the key swing factor for near-term performance.

Rare earth push: Solvay expanded its rare earth strategy with a new feedstock agreement and an additional EUR 15 million to EUR 20 million investment to build heavy rare earth separation capacity, with industrial-scale DyTb production targeted for fall 2026.

Cash and debt: Free cash flow was EUR 15 million in H1, but Q3 cash flow should remain under pressure from transformation spending; underlying net debt was EUR 1.8 billion at the end of June and leverage was temporarily above 2x.

Cost discipline: The company delivered EUR 26 million of cost savings in Q2 and said its structural savings are offsetting inflation, even as transformation expenses remain heavy this year.

Key Financials
Underlying net sales
slightly over EUR 1 billion
Underlying EBITDA
EUR 187 million
EBITDA margin
18.1%
Cost savings
EUR 26 million
EBITDA impact from Middle East conflict
around EUR 20 million
Free cash flow to Solvay shareholders
EUR 15 million
Free cash flow in Q2
minus EUR 11 million
CapEx
approximately EUR 140 million in H1
Working capital outflow
minus EUR 79 million in H1
Cash outflow from provisions
EUR 106 million in H1
Transformation expenses
approximately EUR 90 million of cash outflow in 2026
Underlying net debt
EUR 1.8 billion
Leverage ratio
above 2x
Corporate segment EBITDA
minus EUR 25 million
Rare earth investment
EUR 15 million to EUR 20 million
Rare earth business size
8% of group sales
Earnings Call Recording
Other Earnings Calls

Management

Mr. Philippe Kehren
CEO, Chairman of Executive Committee & Director
No Bio Available
Mr. Alexandre Blum
Chief Financial and Strategy Officer & Member of Executive Committee
No Bio Available
Mr. Lanny Duvall
COO & Member of Executive Committee
No Bio Available
Dr. Mark Van Bijsterveld
Chief People Officer & Member of Executive Committee
No Bio Available
Ms. Lisa Jane Brown
General Counsel, Corporate Secretary & Member of Executive Committee
No Bio Available
Mr. Michael Finelli
Chief Technology Officer
No Bio Available
Ms. An Nuyttens
President of Aroma Performance & Silica Businesses
No Bio Available
Mr. Vincent Kamel
President of Performance Polyamides
No Bio Available
Mr. J. Michael Radossich
President of Novecare Business
No Bio Available
Mr. Carlos Silveira
President of Peroxides GBU
No Bio Available

Contacts

Address
BRUXELLES-CAPITALE
Brussels
RUE DE RANSBEEK 310
Contacts
+3222642111
www.solvay.com